Department of PhilosophyWestern Arts and Humanities

Charles Weijer

weijer

Canada Research Chair in Bioethics
Professor, Joint Appointment with Department of Medicine, Cross Appointment with Department of Epidemiology and Biostatistics
Member, Rotman Institute of Philosophy
Bioethics, Research ethics
BMdSc, MD Alberta; BA(Hons), MSc, PhD McGill

Phone: 519-661-2111 ext. 80090
Office: Stevenson Hall 2150B
Email: cweijer@uwo.ca
Website: www.rotman.uwo.ca

Teaching 2015-16

Selected Publications

Books

Weijer C, Skelton A, Brennan S (eds.). Bioethics in Canada. Toronto: Oxford University Press Canada, 2013. 

Articles

Weijer C, Bruni T, Gofton T, et al.. Ethical considerations in functional magnetic resonance imaging research in acutely comatose patients. Brain 2015: in press.

Graham M, Weijer C, Peterson A, et al.. Acknowledging awareness: Informing families of individual research results for patients in vegetative states. Journal of Medical Ethics 2015; 41: 534–538.

Graham M, Weijer C, Cruse D, et al.. An ethics of welfare for behaviorally nonresponsive patients with covert awareness. AJOB Neuroscience 2015; 6(2): 31–41.

Weijer C, Peterson A, Webster F, et al.. Ethics of neuroimaging after serious brain injury. BMC Medical Ethics 2014: 15: 41. [13 pages]

Peterson A, Naci L, Weijer C, et al.. Assessing decision making capacity in the behaviorally non-responsive patient with residual covert awareness. AJOB Neuroscience 2013; 4(4): 3–14.

Hey SP, Heilig CM, Weijer C. Accumulating evidence and research organization (AERO) model: A new tool for representing, analyzing, and planning a translational research program. Trials 2013; 14: 159. [10 pages]

Taljaard M, Weijer C, Grimshaw JM, et al.. The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomised Trials: A précis for researchers and research ethics committees. British Medical Journal 2013; 346: f2838. [7 pages]

Hey SP, Weijer C. Assay sensitivity and the epistemic contexts of clinical trials. Perspectives in Biology and Medicine 2013; 56(1): 1–17.

Weijer C, Grimshaw JM, Eccles MP, et al.. The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials. PLoS Medicine 2012; 9(11): e1001346. [9 pages]

Gallo A, Weijer C, White A, et al.. What is the role and authority of gatekeepers in cluster randomized trials in health research? Trials 2012; 13: 116. [14 pages]

McRae AD, Weijer C, Binik A, et al.. When is informed consent required in cluster randomized trials in health research? Trials 2011; 12: 202. [13 pages]

McRae AD, Weijer C, Binik A, et al.. Who is the research subject in cluster randomized trials? Trials 2011; 12: 183. [12 pages]

Binik A, Weijer C, McRae AD, et al.. Does clinical equipoise apply to cluster randomized trials in health research? Trials 2011: 12: 118. [11 pages]

Weijer C, Grimshaw JM, Taljaard M, et al.. Ethical issues posed by cluster randomized trials in health research. Trials 2011; 12: 100. [11 pages]

Taljaard M, McRae A, Weijer C, et al.. Inadequate reporting of research ethics review and informed consent in cluster randomized trials: review of a representative sample of published trials. British Medical Journal 2011; 342: d2496. [9 pages]

Book Chapters

Weijer C, Miller PB, Graham M. The duty of care and equipoise in randomized controlled trials. In: Arras JD, Kukla R, Fenton E (eds.). Routledge Companion to Bioethics. Routledge: New York, 2015: 200–214.

Weijer C, Lanata CF, Plowe CV. Ethical considerations in the conduct of vaccine trials in developing countries. In: Levine MM, Dougan G, Good MF, Liu MA, Nabel GJ, Nataro JP, Rappuoli R (eds.). New Generation Vaccines (4th edition). New York: Informa Health Care, Inc., 2010: 59–65.